KnowledgeNCT06350643
Quit and Screen Project
A study testing Quit and Screen Project training and G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training in people with Knowledge and Attitudes, run by University of Arkansas at 1 site in United States.
Trial summary
The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases. Read more about this study
- Who is it for?
- Ages 21 to 85 yearsHealthy volunteers can take part
- Conditions the study is for
- Knowledge, Attitudes, Behavioral Intention
- What is being tested?
- Quit and Screen Project training and G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jan 2027to 1 Jul 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 85 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Current National Medical Association (NMA) member
- Serves a patient clientele who smokes
- At least 20% of time (1 day per week) devoted to clinical care
- Currently screens clients for tobacco use in the clinic
- Have the capacity to refer smokers to a patient navigator
- Willing to provide informed consent
- Will provide contact email, address and phone.
Who cannot join
- None
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Virginia Commonwealth Univesity
Richmond, Virginia, 23284
Mignonne Guy, PhD, 804-828-1731, mguy@vcu.edu
Mignonne Guy, PhD
About this study
Official title: The Quit and Screen Project
The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.
The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.
Read the detailed description
This clinical trial tests the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition.
In partnership with the National Medical Association, investigators will recruit 300 healthcare providers who provide clinical services to individuals who smoke smoke. Interested providers will be screened; if eligible, the will complete informed consent. Providers who complete the online consent and agree to enroll in the training study will be individually randomized to one of 2 conditions: The Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training. After randomization, providers will complete a pre-test assessing their knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography. Providers will then complete an online training. Providers will then complete a post-test assessing their 1) knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography and 2) preferences for the online materials and satisfaction with the training. Feasibility will be assessed using data on provider interest in the training and training reach.
- Conditions
- Knowledge, Attitudes, Behavioral Intention
- Being tested
- Quit and Screen Project training, G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training
- Medical subject headings
- Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Quit and Screen Project trainingOther
This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.
G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening trainingOther
The G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers.
| Study group | Role | What they receive |
|---|---|---|
| Quit and Screen Project training alone | Experimental | Providers in this arm will only complete the Quit and Screen Project training. This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training . Receives: Other: Quit and Screen Project training |
| Quit and Screen Project training + G02 Lung Cancer Screening training | Experimental | In this arm, providers will complete the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training and the Quit and Screen Project training. The Quit and Screen Project training is an online course being developed to fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 Lung Cancer Screening training. Receives: Other: Quit and Screen Project training; Other: G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Familiarity with treatment guidelines for tobacco and nicotine treatment
Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Weaver et al. 2012 Provider Attitudes and Perceptions about smoking cessation
These questions assessed providers perceptions about the benefits of smoking cessation and the benefits of providers advising patients to quit smoking.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Weaver et al. 2012 Provider Perceptions about provider barriers to providing smoking cessation interventions to patients
Perceptions about provider barriers to addressing smoking cessation with patient were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Provider Perceptions about patient barriers to smoking cessation
Perceptions about patient barriers to smoking cessation were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Behavioral intentions to screen and advise patients about smoking cessation
A set of questions based on the Theory of Planned Behavior assessed provider's intention to screen patients for tobacco use and provide them interventions and referrals for treatment.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Familiarity with lung cancer screening guidelines
Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Knowledge about low dose computed tomography for lung cancer screening
Familiarity with treatment guidelines was assessed using an modified question from the questions published by Kota et al. 2022, Carter-Bawa et al. 2022, and the National Cancer Institute National Survey of Primary Care Physicians' Recommendations \& Practices for Breast, Cervical, Lung, \& Colorectal Cancer Screening.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Perceptions about shared decision-making for low dose computed tomography for lung cancer screening
Questions were modified from the questions published by Forcino et al. in 2018.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Perceptions about provider barriers to referring patients to low dose computed tomography for lung cancer screening
Questions were modified from questions published by Coughlin et al. 2020.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Provider Perceptions about patient barriers to get screened for lung cancer
Perceptions about patient barriers to getting screened for lung cancer were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Behavioral intentions to advise patients to get screened for lung cancer via low dose computed tomography
A set of questions based on the Theory of Planned Behavior assessed provider's intention to advise patients who smoke to get screened for lung cancer via low dose computed tomography.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Secondary outcomes (5)
Characteristics of enrolled healthcare providers
Study process tracking metrics will be used to assess the demographic, training, and clinical practice characteristics of providers who enroll in the training.
Measured: This is pre-post design. This outcome will be measured during the pre-test immediately before participants complete the 30-60 minute online training.
Retention: Percent of providers complete the training after enrolling
Study process tracking metrics will be used to assess retention of providers who enroll in the training.
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Adherence to completing training modules: Percent of modules completed
Study process tracking metrics and training completion data will be used to assess the percent of training modules completed (i.e., the number of modules completed divided by the total available modules).
Measured: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Preferences regarding training
Questions will assess provider feedback on the online training module.
Measured: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.
Satisfaction with training
Questions will assess provider satisfaction on the online training module.
Measured: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Apr 2024
- Study start1 Jan 2027 (estimated)
- Primary completion1 Apr 2027 (estimated)
- Study completion1 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for KnowledgeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Arkansas
- Sponsor type
- University, hospital or other
- Collaborators
- Virginia Commonwealth University, Coalition for a Tobacco Free Arkansas, National Institute on Minority Health and Health Disparities (NIMHD), National Medical Association
- Responsible party
- Sponsor
- Investigators
- Pebbles Fagan, PhD, MPH, Principal investigator, University of ArkansasMignonne Guy, PhD, Principal investigator, Virginia Commonwealth UniversityAshley Clawson, PhD, Principal investigator, University of Arkansas
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06350643
- Sponsor's protocol ID
- 287064
- Other IDs
- P50MD017319-03S1
- Status last verified
- Oct 2026
- First submitted
- 6 Mar 2024
- Last updated
- 27 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Quit and Screen Project
- ClinicalTrials.gov ID
- NCT06350643
- Acronym / sponsor ID
- 287064
- Conditions
- Knowledge, Attitudes, Behavioral Intention
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- University of ArkansasUniversity, hospital or other
- Collaborators
- Virginia Commonwealth University, Coalition for a Tobacco Free Arkansas, National Institute on Minority Health and Health Disparities (NIMHD), National Medical Association
- Study start
- 1 Jan 2027 (estimated)
- Primary completion
- 1 Apr 2027 (estimated)
- Study completion
- 1 Jul 2027 (estimated)
- First posted
- 5 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.
The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.
Detailed description
This clinical trial tests the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition.
In partnership with the National Medical Association, investigators will recruit 300 healthcare providers who provide clinical services to individuals who smoke smoke. Interested providers will be screened; if eligible, the will complete informed consent. Providers who complete the online consent and agree to enroll in the training study will be individually randomized to one of 2 conditions: The Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training. After randomization, providers will complete a pre-test assessing their knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography. Providers will then complete an online training. Providers will then complete a post-test assessing their 1) knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography and 2) preferences for the online materials and satisfaction with the training. Feasibility will be assessed using data on provider interest in the training and training reach.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Quit and Screen Project training alone | Experimental | Other: Quit and Screen Project trainingProviders in this arm will only complete the Quit and Screen Project training. This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training . |
| Quit and Screen Project training + G02 Lung Cancer Screening training | Experimental | Other: Quit and Screen Project training, Other: G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening trainingIn this arm, providers will complete the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training and the Quit and Screen Project training. The Quit and Screen Project training is an online course being developed to fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 Lung Cancer Screening training. |
Who may qualify
- Ages
- 21 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Current National Medical Association (NMA) member
- Serves a patient clientele who smokes
- At least 20% of time (1 day per week) devoted to clinical care
- Currently screens clients for tobacco use in the clinic
- Have the capacity to refer smokers to a patient navigator
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Quit and Screen Project trainingThis online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training. | Other | Quit and Screen Project training + G02 Lung Cancer Screening training, Quit and Screen Project training alone |
| G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening trainingThe G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers. | Other | Quit and Screen Project training + G02 Lung Cancer Screening training |
Primary outcome
Familiarity with treatment guidelines for tobacco and nicotine treatment
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.
Weaver et al. 2012 Provider Attitudes and Perceptions about smoking cessation
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
These questions assessed providers perceptions about the benefits of smoking cessation and the benefits of providers advising patients to quit smoking.
Weaver et al. 2012 Provider Perceptions about provider barriers to providing smoking cessation interventions to patients
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Perceptions about provider barriers to addressing smoking cessation with patient were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Provider Perceptions about patient barriers to smoking cessation
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Perceptions about patient barriers to smoking cessation were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Behavioral intentions to screen and advise patients about smoking cessation
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
A set of questions based on the Theory of Planned Behavior assessed provider's intention to screen patients for tobacco use and provide them interventions and referrals for treatment.
Familiarity with lung cancer screening guidelines
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.
Knowledge about low dose computed tomography for lung cancer screening
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Familiarity with treatment guidelines was assessed using an modified question from the questions published by Kota et al. 2022, Carter-Bawa et al. 2022, and the National Cancer Institute National Survey of Primary Care Physicians' Recommendations \& Practices for Breast, Cervical, Lung, \& Colorectal Cancer Screening.
Perceptions about shared decision-making for low dose computed tomography for lung cancer screening
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Questions were modified from the questions published by Forcino et al. in 2018.
Perceptions about provider barriers to referring patients to low dose computed tomography for lung cancer screening
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Questions were modified from questions published by Coughlin et al. 2020.
Provider Perceptions about patient barriers to get screened for lung cancer
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Perceptions about patient barriers to getting screened for lung cancer were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Behavioral intentions to advise patients to get screened for lung cancer via low dose computed tomography
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
A set of questions based on the Theory of Planned Behavior assessed provider's intention to advise patients who smoke to get screened for lung cancer via low dose computed tomography.
5 secondary outcomes
Characteristics of enrolled healthcare providers
Time frame: This is pre-post design. This outcome will be measured during the pre-test immediately before participants complete the 30-60 minute online training.
Retention: Percent of providers complete the training after enrolling
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Adherence to completing training modules: Percent of modules completed
Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.
Preferences regarding training
Time frame: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.
Satisfaction with training
Time frame: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Knowledge
Not yet recruiting
The Effect of Health Belief Model-Based HPV Infection and Vaccination Education on University Students' Knowledge and Health Beliefs
Health Belief Model, Nursing Students
Recruiting
The Orientation Intervention to Rapid Response Teams (ORIENT-RRT) Study: A Quasi-Experimental Study
Deterioration, Clinical
RecruitingObservational study
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
Malignant Solid Tumors, Other Neoplasms Solid Tumors
Active, not recruiting
A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
Childhood Cancer, Survivorship
Not yet recruiting
Pilot Study to Co-create and Implement a Multicomponent Intervention to Reduce Mental Health Stigma in Primary Care
Mental Health, Stigma of Mental Illness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Pebbles Fagan, PhD, MPH principal investigator
University of Arkansas
Mignonne Guy, PhD principal investigator
Virginia Commonwealth University
Ashley Clawson, PhD principal investigator
University of Arkansas
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Quit and Screen Project training and G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training in people with Knowledge and Attitudes, run by University of Arkansas at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mignonne Guy, PhD (804-828-1731, mguy@vcu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Familiarity with treatment guidelines for tobacco and nicotine treatment (time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.